Donate

Researchers

New Investigator

FAST continually seeks to expand its pool of researchers in the field of AS and offer support to outstanding scientists who are eager to explore and study AS.

These awards will be granted to promising new scientists that are looking to start a significant research program focusing on translational research in Angelman syndrome, or on technologies specifically relevant to advancing Angelman Syndrome treatment modalities. The applicants for the New Investigator Awards should be new Primary Investigators, within their first five years of an academic position at an institution/university. New Investigator Awards are either one or two year grants, made in one-year allocations, with a maximum recommended funding of $150,000 per year. 

Looking for our deadline?

There isn’t one. All grant applications are considered on a rolling basis. We move as fast so you can too.

Applicants should be within their first five years of an academic position at an institution/university. This award is not intended for those entering industry. The applicant should have either accepted an offer or already been appointed to an academic position at a university/institute, and have a history of research in a relevant field consistent with FASTs goals.

It is expected that the Applicant will use this funding to generate data that can be utilized for future grants and publications, and that the Applicant will attend and present their data at the FAST annual Science Summit. Additionally, the recipient of the New Investigator Award will agree to be considered as a possible scientific advisor in their area of AS research and available for input and review of research proposals to the FAST Scientific Advisory Board. For more information, write to science@cureangelman.org.

Letter of Intent

Applicants are encouraged to submit a Letter of Intent (LOI) to FAST at science@cureangelman.org to determine the feasibility of a potential request prior to applying. LOI’s must be submitted as one PDF file containing the following information:

  • A brief description of the project including objectives and rationale;

  • An estimate of proposed budget and duration of the project;

  • Preliminary data to support the project; and

  • A CV/Biosketch

The entire LOI (minus the CV) should be no more than 3 pages.

Eligibility

The applicants for the New Investigator Awards should be new Primary Investigators, within their first five years of an academic position at an institution/university. Institutions receiving grants must be recognized as nonprofit. In the US, this means institutions that do not operate to make a profit.  Individuals should have training and experience at least equal to the PhD or MD level.  Awardees are required to pursue their research and academia on a full-time basis, or as specified by the sponsoring institution in accordance with its own policies.  

Duration of Support

The New Investigator Awards are allocated based on the proposed needs of the project. Expedited timelines are encouraged, which will be made in either one- or two-year allocations, pending on the scope of work. Either one or two year grants have a maximum recommended funding of $150,000 per year. In exceptional circumstances where larger grant amounts are needed, individuals may submit an inquiry, along with a letter of intent, to science@cureangelman.org. This letter should provide a justification for the increased funding requirement.

For one-year grants, recipients are required to furnish a financial report and bi-yearly progress report within six months of the award activation date, and a final report 60-days following the conclusion of the grant if no Year 2 funding is being requested. Quarterly updates at both 3 and 9 months will be provided via email, video, or audio call to share progress with FAST throughout the award period. Second year funding is non-competitive but is based on review of the first year’s progress report. For grants longer than 1 year, a grant renewal application must be submitted at least 8 weeks before the subsequent year of funding is requested along with a progress and financial report. For more information on renewal guidelines please click here.

Allowable Costs

Potential allowable costs include:

  • Reagents and Materials: These may include but are not limited to: gene chips, chemical libraries, acquisition of cell lines, acquisition of animal model lines.

  • Services: These may include, but are not limited to: deep sequencing, proteomics, metabolomics, mass spectrometry, antibody production, and drug/chemical manufacturing.

  • Equipment: FAST will consider the purchase of specialized pieces of equipment or software purchases for specific purchases for specific projects when necessary.

  • Personnel: Including salary and fringe benefits.  Additionally, FAST will fund postdoctoral and graduate students at a salary equivalent to the current NIH guidelines.

  • Indirect Costs: FAST allows up to 5% indirect cost rate to the budget’s modified total direct costs (less those costs specifically excluded) to be included in the total cost of the project. FAST will not pay any indirects on tuition, equipment, software or software licenses. Example: modified total direct costs of $100, 5% indirects would be $5; total cost of project is $105.

  • Travel Costs:  Each award will include a $3,000 travel stipend to allow for the PI and one trainee, when applicable, to travel to the annual FAST scientific symposium, where they may be required to present their current research progress.

Application and Submission Information

Write the research plan: Applicants should download the grant application form and prepare a Research Plan that emphasizes the methods and utilizes the following outline format:

  • Abstract: A succinct description of the proposed work that includes the project’s broad, long-term objectives and specific aims, and a description of the research design and methods.

  • Lay summary: This should include your research objectives and your preliminary work that can be easily interpreted by a lay person. The focus should be on the translational component of your research objectives. (1 page maximum). We are committed to educating the public about the importance of this research and this will be posted on the FAST website if the project is funded.

  • Budget Justification: One page budget with justification is required.

  • Other Support: Please list all active and pending support to ensure there is no scientific, budgetary, or commitment overlap.

  • Facilities and Resources: This section should include any organizational resources available to perform the proposed studies. Identify the facilities to be used (Laboratory, Animal, Computer, Office, Clinical and Other). If appropriate, indicate their capacities, pertinent capabilities, relative proximity and extent of availability to the project. Describe only those resources that are directly applicable to the proposed work.

  • Budget: Applicants must use the budget sheet provided in application materials. If the proposal is multi-year, Applicants must use separate budget sheets per year, fill in the start and end date and applicable amounts for each year of support separately, summing for total amount requested.

  • Hypotheses and Specific Aims: Include specific research questions, objectives and hypotheses. The focus of the applications should be aligned with the FAST mission.

  • Background and Significance: Provide rationale for the research with emphasis on what is needed and why this project would benefit a translational therapeutic research program for Angelman syndrome.

  • Preliminary studies: Include any preliminary data you have gathered which supports the specific research question(s).

  • Research Design and Methods: Include study design, methods, and expected results. Limitations and Potential Pitfalls: Discuss potential difficulties and/or limitations in achieving aims and alternative approaches to achieving aims.

  • Milestone Timeline: A research timeline will be provided with milestone goals to be reached during the funding period. These milestones will measure progress made throughout the award period and help determine Year 2 funding if applicable.

  • Biosketch: The biosketch of the PI and any collaborative personnel for the project. Please use the current NIH Biosketch Format.

Formatting

  • Proposal in Arial or Times New Roman size 11 point font, single or 1.15 spacing; Margins no less than 0.5”;Include a header on each page indicating name of PI (Last, First), page number;

  • Figures and figure legends included within the 5 page limit; and

  • Only PDF files accepted for review.

Submit Application Materials

Applications must be submitted electronically to science@cureangelman.org. Only PDF files will be accepted and reviewed. Applications will be accepted on a rolling basis. Any questions about the application process should be directed to science@cureangelman.org.

For a complete list of FAST grant policies download a printable copy.

Angelman Syndrome News